Seroba Life Sciences vs Paul Lanks

Seroba Life Sciences vs Paul Lanks compared for founders deciding who to pitch. Stage focus, check size, and sector fit compared side by side.

Seroba Life Sciences vs Paul Lanks

Seroba Life Sciences is a venture capital based in Dublin, Ireland. Paul Lanks is a venture capital based in New York across 200 portfolio companies. Both invest in Biotech, while Seroba Life Sciences also covers Digital Health and Healthcare and Paul Lanks covers Aerospace Defense and Artificial Intelligence. On stage, Seroba Life Sciences is active at undisclosed stages and Paul Lanks at Growth and Seed.

Investor type: Seroba Life Sciences — Venture Capital; Paul Lanks — Venture Capital
Headquarters: Seroba Life Sciences — Dublin, Ireland; Paul Lanks — New York
Portfolio companies: Seroba Life Sciences — not disclosed; Paul Lanks — 200
Sectors: Seroba Life Sciences — Biotech, Digital Health, Healthcare; Paul Lanks — Aerospace Defense, Artificial Intelligence, Biotech
Stages: Seroba Life Sciences — not disclosed; Paul Lanks — Growth, Seed

Similar investors

Investors like Seroba Life Sciences · Investors like Paul Lanks · Seroba Life Sciences co-investors · Full investor directory

Resources Pricing

Resources

Join freeJoin for free Free · no credit card

Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

AI-scored pitch deck
Matched investor list
Personalized outreach drafts

Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

All
Seed & Pre-Seed
Series A & B
Fintech
SaaS & Dev Tools
Consumer & Social
Marketplace & Frontier
Mistakes to Avoid
Checklist
How to Send
Design
Length
Order
Storytelling
Investor Q&A
One-Pager
Email Templates
Data Room
Investor Update
Term Sheet
SAFE vs Priced
Due Diligence
Timeline
Metrics
Valuation
Cap Table
Pipeline
Board
Objections
References
Closing
Bridge Round
Down Round
Secondary Sale
Investor Rejection
First Meeting
Second Meeting
Partner Meeting
Post-Mortem
Update Cadence
Angel Round
Option Pool Shuffle
Fundraise Pause
Vetting VCs
First 90 Days
First Board Meeting
Reference Calls
NDA Template
Bylaws Template

LibraryPitch Deck Examples

Slide-by-slide guide

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

LibraryArticles

•By Alejandro Cremades